90 related articles for article (PubMed ID: 23099872)
1. [Impact of antiretroviral therapy under different treatment regimens].
Rossi SM; Maluf EC; Carvalho DS; Ribeiro CE; Battaglin CR
Rev Panam Salud Publica; 2012 Aug; 32(2):117-23. PubMed ID: 23099872
[TBL] [Abstract][Full Text] [Related]
2. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
3. The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis.
Abara WE; Xu J; Adekeye OA; Rust G
AIDS Care; 2016 Aug; 28(8):1013-7. PubMed ID: 26886075
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with non-adherence to antiretroviral therapy in adults with AIDS in the first six months of treatment in Salvador, Bahia State, Brazil.
Silva JA; Dourado I; Brito AM; Silva CA
Cad Saude Publica; 2015 Jun; 31(6):1188-98. PubMed ID: 26200367
[TBL] [Abstract][Full Text] [Related]
5. Survival of AIDS patients and characteristics of those who died over eight years of highly active antiretroviral therapy, at a referral center in northeast Brazil.
Melo LS; Lacerda HR; Campelo E; Moraes E; Ximenes RA
Braz J Infect Dis; 2008 Aug; 12(4):269-77. PubMed ID: 19030724
[TBL] [Abstract][Full Text] [Related]
6. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
Sutton SS; Magagnoli J; Hardin JW
Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
[TBL] [Abstract][Full Text] [Related]
7. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
[TBL] [Abstract][Full Text] [Related]
8. Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks.
Sutton SS; Hardin JW; Bramley TJ; D'Souza AO; Bennett CL
Am J Manag Care; 2016 Apr; 22(4):242-8. PubMed ID: 27143289
[TBL] [Abstract][Full Text] [Related]
9. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
Teixeira C; Dourado Mde L; Santos MP; Brites C
AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
[TBL] [Abstract][Full Text] [Related]
10. Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy.
Saraceni V; da Cruz MM; Lauria Lde M; Durovni B
Braz J Infect Dis; 2005 Jun; 9(3):209-15. PubMed ID: 16224627
[TBL] [Abstract][Full Text] [Related]
11. Survival of adult AIDS patients in a reference hospital of a metropolitan area in Brazil.
Guerreiro MF; Kerr-Pontes LR; Mota RS; Franca MC; Tavora FF; Caminha I
Rev Saude Publica; 2002 Jun; 36(3):278-84. PubMed ID: 12131965
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with AIDS and association with level of education level and race/skin color in South and Southeast Brazil: a cohort study, 1998-1999.
Melo MC; Mesquita FC; Barros MBA; La-Rotta EIG; Donalisio MR
Epidemiol Serv Saude; 2019; 28(1):e2018047. PubMed ID: 30970069
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.
Hacker MA; Petersen ML; Enriquez M; Bastos FI
Rev Panam Salud Publica; 2004 Aug; 16(2):78-83. PubMed ID: 15357932
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
15. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy.
Brito AM; Castilho EA; Szwarcwald CL
Braz J Infect Dis; 2005 Feb; 9(1):9-19. PubMed ID: 15947842
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
17. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
Silveira MP; Maurer P; Guttier MC; Moreira LB
J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
